Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- ChecktodayChange DetectedThe site’s revision number was updated from v3.6.5 to v3.6.6, indicating a behind-the-scenes deployment.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, reflecting a minor update to the record in the page history.SummaryDifference0.0%

- Check29 days agoChange DetectedEnrollment status now indicates recruitment is closed with the added line 'No longer looking for participants'. Deletions remove older status descriptors to reflect the finalized recruitment status.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows revision tag v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page's version metadata.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows Results Submitted instead of No Results Posted, and the revision tag updates to Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a minor version update to the page's underlying software or content.SummaryDifference0.0%

Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.